Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

RSS icon
Thumbnail

Pushing forward on Alzheimer’s disease

This week, the FDA approved the use of F-18 florbetaben (Neuraceq) as a diagnostic amyloid agent to help rule out Alzheimer’s disease (AD). The approval of Neuraceq came a day after the Alzheimer’s Association released its 2014 Alzheimer’s Disease Facts and Figures report, which only underscored the urgency of improving AD diagnostic tools and treatments.

FDA approves Neuraceq amyloid PET agent

F-18 florbetaben, also known as Neuraceq, received U.S. Food and Drug Administration (FDA) approval today as a diagnostic amyloid agent to help rule out Alzheimer’s disease.

Family history of intracranial aneurysms could call for serial screenings

Those who have a family history of aneurysmal subarachnoid hemorrhage (aSAH) will benefit from long-term serial screening, according to a study published in the April 2014 issue of the Lancet Neurology. 

Thumbnail

Zecotek lands U.S. patent for solid-state photo detector

Singapore-based Zecotek Photonics has announced that a new micro-channel avalanche photodiode solid-state photo detector (MAPD) to be used in advanced PET technology has received a notice of allowance from the U.S. Patent Office.

Thumbnail

Nuclear medicine market projected to rise to $24B by 2030

The worldwide nuclear medicine industry is expected to grow an annual percentage rate of 11 percent, mostly due to a steady 30 percent climb in therapeutic radiopharmaneticals every year between 2013 and 2030, according to a March 2014 market report by European research firm MEDraysintell.

‘Liquid biopsy’ could identify multiple neurodegenerative disorders

Aethlon and subsidiary Exosome Sciences, both based in San Diego, Calif., announced earlier this month that the companies have isolated blood-borne biomarkers implicated in multiple neurodegenerative diseases.

Single-screening MRI beneficial for women with breast conservation therapy history

A history of breast conservation therapy (BCT) in patients could be a reasonable indication for single-screening breast MRI in women younger than 50, according to a study published online Mar. 17 by Radiology. 

Medical organizations call for Medicare coverage of CT lung cancer screening

Forty-one of the nation’s largest medical organizations and patient advocacy groups, including the American College of Radiology (ACR), issued a joint letter to the Centers for Medicare & Medicaid Services (CMS) National Coverage and Analysis Group calling for lung cancer screening coverage in line with recent recommendations from the U.S. Preventive Services Task Force (USPSTF).

Displaying 4993 - 5000 of 23546

Around the web

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care.